Efficacy of radiofrequency ablation following transarterial chemoembolisation combined with sorafenib for intermediate stage recurrent hepatocellular carcinoma: a retrospective, multicentre, cohort studyResearch in context

Efficacy of radiofrequency ablation following transarterial chemoembolisation combined with sorafenib for intermediate stage recurrent hepatocellular carcinoma: a retrospective, multicentre, cohort studyResearch in context

Summary: Background: The evidence of radiofrequency ablation (RFA) following transarterial chemoembolisation (TACE) combined with sorafenib for intermediate-stage recurrent hepatocellular carcinoma (RHCC) is limited. Patient responses to this treatment vary because of the heterogeneous nature of RH...

Full description

Bibliographic Details
Main Authors: Xiao-Hui Wang, Wen-Bin Duan, Wei Liang, Hui Li, Xiao-Yan Xie, Shao-Qiang Li, Min-Shan Chen, Ping Liang, Xian-Hai Mao, Qun-Fang Zhou
Format: Article
Language:English
Published: Elsevier 2023-02-01
Series:EClinicalMedicine
Subjects:
Recurrent hepatocellular carcinoma
Intermediate-stage
Transarterial chemoembolisation
Sorafenib
Radiofrequency ablation
Online Access:http://www.sciencedirect.com/science/article/pii/S2589537022005454

Internet

http://www.sciencedirect.com/science/article/pii/S2589537022005454

Similar Items